Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
08/2012
08/07/2012CA2683980C Topical composition comprising n-acetylaldosamines or n-acetylamino acids
08/07/2012CA2463675C Cyclic peptides as g-protein-coupled receptor antagonists
08/07/2012CA2456516C Identification of a dna variant associated with adult type hypolactasia
08/07/2012CA2445421C Von willebrand factor (vwf)-cleaving protease
08/07/2012CA2429216C Novel use of combined 5-ht1a agonists and selective serotonin reuptake inhibitors
08/07/2012CA2319715C Breast cancer resistance protein (bcrp) and the dna which encodes it
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012102405A1 Ring-fused compound
08/02/2012WO2012102361A1 Aromatase activator
08/02/2012WO2012102360A1 Morphinan derivative
08/02/2012WO2012102357A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102355A1 Bicyclic compound and use thereof for medical purposes
08/02/2012WO2012102308A1 Therapeutic agent and preventive agent for diabetes
08/02/2012WO2012102297A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012WO2012102255A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012WO2012102254A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012WO2012101846A1 Therapeutic or prophylactic agent for influenza
08/02/2012WO2012101741A1 Tie-2 activator, agent for maturation, normalization, or stabilization of blood vessels, lymph vessel stabilizing agent, wrinkle prevention/improvement agent, and edema improvement/prevention agent
08/02/2012WO2012100436A1 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof
08/02/2012WO2012100384A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012US20120196932 Use of Medium Chain Triglycerides for the Treatment and Prevention of Alzheimer's Disease and Other Diseases Resulting from Reduced Neuronal Metabolism
08/02/2012US20120196826 Methods for transdifferentiation of body tissues
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120195989 Carboxymethylarginine Production Inhibitor and Collagen Denaturation Inhibitor
08/02/2012US20120195963 Highly purified ethyl epa and other epa derivatives
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012CA2825746A1 Pyrazolopyridine derivative or pharmacologically acceptable salt thereof
08/02/2012CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825157A1 Therapeutic or preventive agent for diabetes
08/02/2012CA2825134A1 Indole derivative, and pharmacologically acceptable salt thereof
08/01/2012EP2481755A1 Antibody capable of recognizing hla class i
08/01/2012EP2481732A1 Condensed ring compound and use thereof
08/01/2012EP2481723A2 Substituted tetracycline compounds
08/01/2012EP2481406A1 Use of piperphentonamine or salts thereof in manufacture of medicaments for preventing / treating brain diseases
08/01/2012EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof
08/01/2012EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
08/01/2012EP2193793B1 Nerve cell death inhibitor
08/01/2012EP2127646B1 Agent for relief or prevention of xerostomia
08/01/2012EP1666472B1 Phenylacetic acid derivative, process for producing the same, and use
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012CN1993333B Triazole derivative
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102617502A Benzoxazole derivatives and application of benzoxazole derivatives to medicines
08/01/2012CN102614578A Chest cavity poison-drawing bag and preparation method thereof
08/01/2012CN102614429A Chinese herbal compound prescription able to induce biological red waves and its preparation
08/01/2012CN102614427A Method for preparing Chinese medicine for treating night sweat
08/01/2012CN102614335A Method for preparing Huoxiang Zhengqi oral liquid
08/01/2012CN102614293A Herbal medicine for treating half-body sweating
08/01/2012CN102613564A Ginseng, cartialgenous and lucid ganoderma capsule and preparation method of ginseng, cartialgenous and lucid ganoderma capsule
08/01/2012CN101643470B Alkyl ether derivatives or salts thereof
08/01/2012CN101423508B Method for preparing flavonoid from lotus leaf and drug application thereof
07/2012
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/31/2012US8232383 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
07/31/2012US8232308 Methods for treating a disease in which Rho kinase is involved
07/31/2012US8232258 NK1 fragment of hepatocyte growth factor/scatter factor (HGF/SF) and variants thereof, and their use
07/31/2012US8231901 Opioid agonist formulations with releasable and sequestered antagonist
07/31/2012CA2703688C Use of bile acid or bile salt fatty acid conjugates
07/31/2012CA2515505C Inhibitor for perioperative blood sugar elevation
07/31/2012CA2506464C Therapeutic agent for glaucoma comprising rho kinase inhibitor and .beta.-blocker
07/31/2012CA2489965C Pharmaceutical compositions for the treatment of diseases related to neurotrophines
07/31/2012CA2478409C Inhibitors of urokinase, their preparation and use
07/31/2012CA2465375C 2-aryl-propionic acids and pharmaceutical compositions containing them
07/31/2012CA2458471C Prostaglandin analogs as chloride channel opener
07/31/2012CA2449999C Compounds and methods for the treatment or prevention of flavivirus infections
07/31/2012CA2404688C Nuclear factor .kappa.b inducing factor
07/31/2012CA2370948C Growth factor homolog zvegf4
07/31/2012CA2358958C Soy depigmenting and skin care compositions
07/26/2012WO2012099477A1 Biosurface engineering
07/26/2012WO2012099247A1 Skin whitening agent
07/26/2012WO2012099238A1 Composition for promoting lipolysis
07/26/2012WO2012099200A1 Pyrazole derivative
07/26/2012WO2012098537A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
07/26/2012WO2012066581A9 Novel conjugates for targeted drug delivery
07/26/2012US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies
07/26/2012US20120190832 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
07/26/2012US20120190668 Enhancement of cellular transplantation using small moleucle modulators of hepatocyte growth factor (scatter factor) activity
07/26/2012US20120190642 Isoflavones for treating mucopolysaccharidoses
07/26/2012US20120190616 Analogues of Insulin-Like Growth Factor-1 (IGF-1) Having Amino Acid Substitution at Position 59
07/26/2012US20120189721 Methods and compositions for heavy metal detoxification
07/26/2012US20120189624 Treatment and prophylaxis of amyloidosis
07/26/2012US20120189604 Purification and isolation of recombinant oxalate degrading enzymes and spray-dried particles containing oxalate degrading enzymes
07/26/2012US20120189586 Human Placental Derived Extracellular Matrix and Uses Therof
07/26/2012US20120189576 3'-[(2Z)-[1-(3,4-DIMETHYLPHENYL)-1,5-DIHYDRO-3-METHYL-5-OXO-4H-PYRAZOL-4-YLIDENE]HYDRAZINO]-2'-HYDROXY-[1,1'-BIPHENYL]-3-CARBOXYLIC ACID bis-(MONOETHANOLAMINE)
07/26/2012US20120189575 Oligodendrocyte Production from Multipotent Neural Stem Cells
07/26/2012US20120189558 Anti-bacterial compositions comprising extracts of eremophila longifolia and methods for use of same
07/26/2012CA2824791A1 Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
07/25/2012EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof
07/25/2012EP2478914A1 Modified erythropoietin to which water-soluble long-chain molecule is added
07/25/2012EP2478010A1 Partial peptide of lacritin
07/25/2012EP2477989A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
07/25/2012EP2477620A1 Method of slowing the aging process by activating sirtuin enzymes with a combination of fucoxanthin and punicic acid
07/25/2012EP2077266B1 2-pyridinecarboxamide derivative having gk-activating activity
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/25/2012EP1333808B1 Electroprocessed composition used in drug delivery and cell encapsulation
07/25/2012EP1322641B1 Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 1564